The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): A single-center, single-arm, exploratory clinical trial.
 
Ji chen Yang
No Relationships to Disclose
 
Wenjie Jiao
No Relationships to Disclose
 
Feng Hua
No Relationships to Disclose
 
Xiaoming Zhao
No Relationships to Disclose
 
Wenfeng Yang
No Relationships to Disclose